These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2387381)

  • 21. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the cat].
    Kaverina NV; Rodionov AP; Berdjajev SJ; Darinskij NW; Sulakvelidze MT; Klemm W
    Pharmazie; 1985 Dec; 40(12):868-9. PubMed ID: 3841606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia].
    Kaverina NV; Lyskovzev VV; Grigoreva JK; Senova ZP; Sulakvelidze MT; Grizenko AN
    Pharmazie; 1985 Dec; 40(12):845-7. PubMed ID: 3841599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
    Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hydrochlorides of N-hydroxyalkyl-alpha-piperidine carboxylic arylamides possessing antiarrhythmic activity].
    Kaverina NV; Skoldinov AP; Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV
    Farmakol Toksikol; 1984; 47(5):25-8. PubMed ID: 6500031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use dependent depression of fast sodium current in heart muscle by the new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015).
    Nilius B; Benndorf K; Schüttler K; Boldt W
    Pharmazie; 1985 Dec; 40(12):852-4. PubMed ID: 2419929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat].
    Poppe H; Femmer K; Kaverina NV; Lyskovzev VV; Grigoreva JK; Mazievskij DD
    Pharmazie; 1985 Dec; 40(12):857-61. PubMed ID: 3841603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiarrhythmic activity of alaglyzin].
    Bryzgalov AO; Volkova EB; Ganenko IuA; Dolgikh MP; Zhukova NA; Sorokina IV; Tolstikova TG
    Eksp Klin Farmakol; 2005; 68(4):24-7. PubMed ID: 16193652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative characteristics of the activity of lithium preparations and anti-arrhythmia agents in strophanthin, calcium chloride and barium chloride arrhythmias in an experiment].
    Galenko-Iaroshevskiĭ PA; Tikhonov AV
    Farmakol Toksikol; 1985; 48(2):64-8. PubMed ID: 3996574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor].
    Galenko-Iaroshevskiĭ PA; Khankoeva AI; Uvarov AV; Reznikov AIu; Galygo DS; Bartashevich VV
    Biull Eksp Biol Med; 1996 Dec; 122(12):665-8. PubMed ID: 9280469
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The anti-arrhythmic activity of quinuclidine derivatives].
    Svistov AS; Skorobogatov VI
    Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine.
    Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P
    Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action].
    Wunderlich H; Stark A; Carstens E; Lohmann D; Grizenko AN; Skoldinov AP
    Pharmazie; 1985 Dec; 40(12):827-30. PubMed ID: 4095140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of the anti-arrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-imino-dibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015)].
    Kaverina NV; Berdjajev SJ; Darinskij NV
    Pharmazie; 1985 Dec; 40(12):840-4. PubMed ID: 3841598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of diuretics on the course of experimental arrhythmias].
    Vorontsov VV
    Farmakol Toksikol; 1986; 49(2):59-61. PubMed ID: 3709777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-arrhythmia properties of marcaine].
    Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
    Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.